TNF-α-dependent regulation of CXCR3 expression modulates neuronal survival during West Nile virus encephalitis

Journal of Neuroimmunology

Volumn 224, Issue 1-2, 2010, Pages 28-38

  Zhang, Bo ^a   Patel, Jigisha ^a   Croyle, Michelle ^a   Diamond, Michael S ^a   Klein, Robyn S ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CNS; CXCL10; CXCR3; Neurons; TNF ; West Nile virus

Indexed keywords

CALCIUM; CASPASE 3; CHEMOKINE RECEPTOR CXCR3; GAMMA INTERFERON INDUCIBLE PROTEIN 10; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; CXCR3 PROTEIN, MOUSE;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; APOPTOSIS; ARTICLE; CALCIUM TRANSPORT; CELL SURVIVAL; CONTROLLED STUDY; DISEASE MODEL; DOWN REGULATION; ENZYME ACTIVATION; FEMALE; IN VITRO STUDY; MALE; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; VIRUS ENCEPHALITIS; WEST NILE FLAVIVIRUS; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; IMMUNOLOGY; KNOCKOUT MOUSE; PATHOLOGY; PHYSIOLOGY; VIROLOGY; WEST NILE FEVER;

ANIMALS; APOPTOSIS; CELL SURVIVAL; CELLS, CULTURED; DOWN-REGULATION; FEMALE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEURONS; RECEPTORS, CXCR3; TUMOR NECROSIS FACTOR-ALPHA; WEST NILE FEVER;

EID: 77955088275     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2010.05.003     Document Type: Article

References (84)

1. Auer K.L., Contessa J., Brenz-Verca S., Pirola L., Rusconi S., Cooper G., Abo A., Wymann M.P., Davis R.J., Birrer M., Dent P. The Ras/Rac1/Cdc42/SEK/JNK/c-Jun cascade is a key pathway by which agonists stimulate DNA synthesis in primary cultures of rat hepatocytes. Mol. Biol. Cell 1998, 9:561-573.
2. Bachis A., Mocchetti I. Brain-derived neurotrophic factor is neuroprotective against human immunodeficiency virus-1 envelope proteins. Ann. NY Acad. Sci. 2005, 1053:247-257.
3. Bergmann C.C., Parra B., Hinton D.R., Ramakrishna C., Dowdell K.C., Stohlman S.A. Perforin and gamma interferon-mediated control of coronavirus central nervous system infection by CD8 T cells in the absence of CD4 T cells. J. Virol. 2004, 78:1739-1750.
4. Binder G.K., Griffin D.E. Interferon-gamma-mediated site-specific clearance of alphavirus from CNS neurons. Science 2001, 293:303-306.
5. Boche D., Cunningham C., Gauldie J., Perry V.H. Transforming growth factor-beta 1-mediated neuroprotection against excitotoxic injury in vivo. J. Cereb. Blood Flow Metab. 2003, 23:1174-1182.
6. Bruce A.J., Boling W., Kindy M.S., Peschon J., Kraemer P.J., Carpenter M.K., Holtsberg F.W., Mattson M.P. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nat. Med. 1996, 2:788-794.
7. Bruce-Keller A.J., Geddes J.W., Knapp P.E., McFall R.W., Keller J.N., Holtsberg F.W., Parthasarathy S., Steiner S.M., Mattson M.P. Anti-death properties of TNF against metabolic poisoning: mitochondrial stabilization by MnSOD. J. Neuroimmunol. 1999, 93:53-71.
8. Cambien B., Karimdjee B.F., Richard-Fiardo P., Bziouech H., Barthel R., Millet M.A., Martini V., Birnbaum D., Scoazec J.Y., Abello J., Al Saati T., Johnson M.G., Sullivan T.J., Medina J.C., Collins T.L., Schmid-Alliana A., Schmid-Antomarchi H. Organ-specific inhibition of metastatic colon carcinoma by CXCR3 antagonism. Br. J. Cancer 2009, 100:1755-1764.
9. Campbell G.L., Marfin A.A., Lanciotti R.S., Gubler D.J. West Nile virus. Lancet Infect. Dis. 2002, 2:519-529.
10. Carpenter D., Henderson G., Hsiang C., Osorio N., BenMohamed L., Jones C., Wechsler S.L. Introducing point mutations into the ATGs of the putative open reading frames of the HSV-1 gene encoding the latency associated transcript (LAT) reduces its anti-apoptosis activity. Microb. Pathog. 2008, 44:98-102.
11. Cheeran M.C., Hu S., Sheng W.S., Rashid A., Peterson P.K., Lokensgard J.R. Differential responses of human brain cells to West Nile virus infection. J. Neurovirol. 2005, 11:512-524.
12. Cheng B., Christakos S., Mattson M.P. Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis. Neuron 1994, 12:139-153.
13. Coughlan C.M., McManus C.M., Sharron M., Gao Z., Murphy D., Jaffer S., Choe W., Chen W., Hesselgesser J., Gaylord H., Kalyuzhny A., Lee V.M., Wolf B., Doms R.W., Kolson D.L. Expression of multiple functional chemokine receptors and monocyte chemoattractant protein-1 in human neurons. Neuroscience 2000, 97:591-600.
14. Daffis S., Samuel M.A., Keller B.C., Gale M., Diamond M.S. Cell-specific IRF-3 responses protect against West Nile virus infection by interferon-dependent and -independent mechanisms. PLoS Pathog. 2007, 3:e106.
15. Das S., Basu A. Japanese encephalitis virus infects neural progenitor cells and decreases their proliferation. J. Neurochem. 2008, 106:1624-1636.
16. Datta D., Flaxenburg J.A., Laxmanan S., Geehan C., Grimm M., Waaga-Gasser A.M., Briscoe D.M., Pal S. Ras-induced modulation of CXCL10 and its receptor splice variant CXCR3-B in MDA-MB-435 and MCF-7 cells: relevance for the development of human breast cancer. Cancer Res. 2006, 66:9509-9518.
17. Diamond M.S., Shrestha B., Marri A., Mahan D., Engle M. B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus. J. Virol. 2003, 77:2578-2586.
18. Dolga A.M., Granic I., Blank T., Knaus H.G., Spiess J., Luiten P.G., Eisel U.L., Nijholt I.M. TNF-alpha-mediates neuroprotection against glutamate-induced excitotoxicity via NF-kappaB-dependent up-regulation of K2.2 channels. J. Neurochem. 2008, 107:1158-1167.
19. Dopp J.M., Mackenzie-Graham A., Otero G.C., Merrill J.E. Differential expression, cytokine modulation, and specific functions of type-1 and type-2 tumor necrosis factor receptors in rat glia. J. Neuroimmunol. 1997, 75:104-112.
20. Ehlert J.E., Addison C.A., Burdick M.D., Kunkel S.L., Strieter R.M. Identification and partial characterization of a variant of human CXCR3 generated by posttranscriptional exon skipping. J. Immunol. 2004, 173:6234-6240.
21. Feldman E.D., Weinreich D.M., Carroll N.M., Burness M.L., Feldman A.L., Turner E., Xu H., Alexander H.R. Interferon gamma-inducible protein 10 selectively inhibits proliferation and induces apoptosis in endothelial cells. Ann. Surg. Oncol. 2006, 13:125-133.
22. Fontaine V., Mohand-Said S., Hanoteau N., Fuchs C., Pfizenmaier K., Eisel U. Neurodegenerative and neuroprotective effects of tumor Necrosis factor (TNF) in retinal ischemia: opposite roles of TNF receptor 1 and TNF receptor 2. J. Neurosci. 2002, 22:RC216.
23. Furukawa K., Mattson M.P. The transcription factor NF-kappaB mediates increases in calcium currents and decreases in NMDA- and AMPA/kainate-induced currents induced by tumor necrosis factor-alpha in hippocampal neurons. J. Neurochem. 1998, 70:1876-1886.
24. Ghoshal A., Das S., Ghosh S., Mishra M.K., Sharma V., Koli P., Sen E., Basu A. Proinflammatory mediators released by activated microglia induces neuronal death in Japanese encephalitis. Glia 2007, 55:483-496.
25. Giuliani N., Bonomini S., Romagnani P., Lazzaretti M., Morandi F., Colla S., Tagliaferri S., Lasagni L., Annunziato F., Crugnola M., Rizzoli V. CXCR3 and its binding chemokines in myeloma cells: expression of isoforms and potential relationships with myeloma cell proliferation and survival. Haematologica 2006, 91:1489-1497.
26. Glass W.G., Lim J.K., Cholera R., Pletnev A.G., Gao J.L., Murphy P.M. Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection. J. Exp. Med. 2005, 202:1087-1098.
27. Goldberg S.H., van der Meer P., Hesselgesser J., Jaffer S., Kolson D.L., Albright A.V., Gonzalez-Scarano F., Lavi E. CXCR3 expression in human central nervous system diseases. Neuropathol. Appl. Neurobiol. 2001, 27:127-138.
28. Hallenbeck J.M. The many faces of tumor necrosis factor in stroke. Nat. Med. 2002, 8:1363-1368.
29. Hirota Y., Osuga Y., Koga K., Yoshino O., Hirata T., Morimoto C., Harada M., Takemura Y., Nose E., Yano T., Tsutsumi O., Taketani Y. The expression and possible roles of chemokine CXCL11 and its receptor CXCR3 in the human endometrium. J. Immunol. 2006, 177:8813-8821.
30. Hunsperger E.A., Roehrig J.T. Temporal analyses of the neuropathogenesis of a West Nile virus infection in mice. J. Neurovirol. 2006, 12:129-139.
31. Janelsins M.C., Mastrangelo M.A., Park K.M., Sudol K.L., Narrow W.C., Oddo S., LaFerla F.M., Callahan L.M., Federoff H.J., Bowers W.J. Chronic neuron-specific tumor necrosis factor-alpha expression enhances the local inflammatory environment ultimately leading to neuronal death in 3xTg-AD mice. Am. J. Pathol. 2008, 173:1768-1782.
32. Kaul M., Ma Q., Medders K.E., Desai M.K., Lipton S.A. HIV-1 coreceptors CCR5 and CXCR4 both mediate neuronal cell death but CCR5 paradoxically can also contribute to protection. Cell Death Differ. 2007, 14:296-305.
33. Kimura T., Griffin D.E. Extensive immune-mediated hippocampal damage in mice surviving infection with neuroadapted Sindbis virus. Virology 2003, 311:28-39.
34. Klein R.S., Rubin J.B., Gibson H.D., DeHaan E.N., Alvarez-Hernandez X., Segal R.A., Luster A.D. SDF-1 alpha induces chemotaxis and enhances Sonic hedgehog-induced proliferation of cerebellar granule cells. Development 2001, 128:1971-1981.
35. Klein R.S., Lin E., Zhang B., Luster A.D., Tollett J., Samuel M.A., Engle M., Diamond M.S. Neuronal CXCL10 directs CD8+ T-cell recruitment and control of West Nile virus encephalitis. J. Virol. 2005, 79:11457-11466.
36. Knoblach S.M., Fan L., Faden A.I. Early neuronal expression of tumor necrosis factor-alpha after experimental brain injury contributes to neurological impairment. J. Neuroimmunol. 1999, 95:115-125.
37. Komatsu T., Ireland D.D., Chen N., Reiss C.S. Neuronal expression of NOS-1 is required for host recovery from viral encephalitis. Virology 1999, 258:389-395.
38. Lafon M. Immune evasion, a critical strategy for rabies virus. Dev. Biol. Basel 2008, 131:413-419.
39. Lasagni L., Francalanci M., Annunziato F., Lazzeri E., Giannini S., Cosmi L., Sagrinati C., Mazzinghi B., Orlando C., Maggi E., Marra F., Romagnani S., Serio M., Romagnani P. An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4. J. Exp. Med. 2003, 197:1537-1549.
40. Lavi E., Wang Q. The protective role of cytotoxic T cells and interferon against coronavirus invasion of the brain. Adv. Exp. Med. Biol. 1995, 380:145-149.
41. Li H., Gang Z., Yuling H., Luokun X., Jie X., Hao L., Li W., Chunsong H., Junyan L., Mingshen J., Youxin J., Feili G., Boquan J., Jinquan T. Different neurotropic pathogens elicit neurotoxic CCR9- or neurosupportive CXCR3-expressing microglia. J. Immunol. 2006, 177:3644-3656.
42. Liu Y., Blanden R.V., Mullbacher A. Identification of cytolytic lymphocytes in West Nile virus-infected murine central nervous system. J. Gen. Virol. 1989, 70(Pt 3):565-573.
43. Luster A.D., Weinshank R.L., Feinman R., Ravetch J.V. Molecular and biochemical characterization of a novel gamma-interferon-inducible protein. J. Biol. Chem. 1988, 263:12036-12043.
44. Madeddu F., Naska S., Bozzi Y. BDNF down-regulates the caspase 3 pathway in injured geniculo-cortical neurones. NeuroReport 2004, 15:2045-2049.
45. Marchetti L., Klein M., Schlett K., Pfizenmaier K., Eisel U.L. Tumor necrosis factor (TNF)-mediated neuroprotection against glutamate-induced excitotoxicity is enhanced by N-methyl-D-aspartate receptor activation. Essential role of a TNF receptor 2-mediated phosphatidylinositol 3-kinase-dependent NF-kappa B pathway. J. Biol. Chem. 2004, 279:32869-32881.
46. Matsubara K., Kodera M., Nigami H., Yura K., Fukaya T. Reversible splenial lesion in influenza virus encephalopathy. Pediatr. Neurol. 2007, 37:431-434.
47. Mattson M.P., Goodman Y., Luo H., Fu W., Furukawa K. Activation of NF-kappaB protects hippocampal neurons against oxidative stress-induced apoptosis: evidence for induction of manganese superoxide dismutase and suppression of peroxynitrite production and protein tyrosine nitration. J. Neurosci. Res. 1997, 49:681-697.
48. Nelson T.E., Gruol D.L. The chemokine CXCL10 modulates excitatory activity and intracellular calcium signaling in cultured hippocampal neurons. J. Neuroimmunol. 2004, 156:74-87.
49. Ohmori Y., Wyner L., Narumi S., Armstrong D., Stoler M., Hamilton T.A. Tumor necrosis factor-alpha induces cell type and tissue-specific expression of chemoattractant cytokines in vivo. Am. J. Pathol. 1993, 142:861-870.
50. Oliphant T., Engle M., Nybakken G.E., Doane C., Johnson S., Huang L., Gorlatov S., Mehlhop E., Marri A., Chung K.M., Ebel G.D., Kramer L.D., Fremont D.H., Diamond M.S. Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus. Nat. Med. 2005, 11:522-530.
51. Oya A., Kurane I. Japanese encephalitis for a reference to international travelers. J. Travel Med. 2007, 14:259-268.
52. Parra B., Lin M.T., Stohlman S.A., Bergmann C.C., Atkinson R., Hinton D.R. Contributions of Fas-Fas ligand interactions to the pathogenesis of mouse hepatitis virus in the central nervous system. J. Virol. 2000, 74:2447-2450.
53. Prikhod'ko G.G., Prikhod'ko E.A., Pletnev A.G., Cohen J.I. Langat flavivirus protease NS3 binds caspase-8 and induces apoptosis. J. Virol. 2002, 76:5701-5710.
54. Ramanathan M.P., Chambers J.A., Pankhong P., Chattergoon M., Attatippaholkun W., Dang K., Shah N., Weiner D.B. Host cell killing by the West Nile Virus NS2B-NS3 proteolytic complex: NS3 alone is sufficient to recruit caspase-8-based apoptotic pathway. Virology 2006, 345:56-72.
55. Rosenblum J.M., Zhang Q.W., Siu G., Collins T.L., Sullivan T., Dairaghi D.J., Medina J.C., Fairchild R.L. CXCR3 antagonism impairs the development of donor-reactive, IFN-gamma-producing effectors and prolongs allograft survival. Transplantation 2009, 87:360-369.
56. Rossi C.P., McAllister A., Tanguy M., Kagi D., Brahic M. Theiler's virus infection of perforin-deficient mice. J. Virol. 1998, 72:4515-4519.
57. Samuel M.A., Diamond M.S. Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival. J. Virol. 2005, 79:13350-13361.
58. Samuel M.A., Morrey J.D., Diamond M.S. Caspase 3-dependent cell death of neurons contributes to the pathogenesis of West Nile virus encephalitis. J. Virol. 2007, 81:2614-2623.
59. Schwarz J.B., Langwieser N., Langwieser N.N., Bek M.J., Seidl S., Eckstein H.H., Lu B., Schomig A., Pavenstadt H., Zohlnhofer D. Novel role of the CXC chemokine receptor 3 in inflammatory response to arterial injury: involvement of mTORC1. Circ. Res. 2009, 104:189-200. 188p following 200.
60. Sejvar J.J., Haddad M.B., Tierney B.C., Campbell G.L., Marfin A.A., Van Gerpen J.A., Fleischauer A., Leis A.A., Stokic D.S., Petersen L.R. Neurologic manifestations and outcome of West Nile virus infection. Jama 2003, 290:511-515.
61. Shafee N., AbuBakar S. Dengue virus type 2 NS3 protease and NS2B-NS3 protease precursor induce apoptosis. J. Gen. Virol. 2003, 84:2191-2195.
62. Shrestha B., Diamond M.S. Role of CD8+ T cells in control of West Nile virus infection. J. Virol. 2004, 78:8312-8321.
63. Shrestha B., Gottlieb D., Diamond M.S. Infection and injury of neurons by West Nile encephalitis virus. J. Virol. 2003, 77:13203-13213.
64. Shrestha B., Samuel M.A., Diamond M.S. CD8+ T cells require perforin to clear West Nile virus from infected neurons. J. Virol. 2006, 80:119-129.
65. Shrestha B., Wang T., Samuel M.A., Whitby K., Craft J., Fikrig E., Diamond M.S. Gamma interferon plays a crucial early antiviral role in protection against West Nile virus infection. J. Virol. 2006, 80:5338-5348.
66. Shrestha B., Zhang B., Purtha W.E., Klein R.S., Diamond M.S. Tumor necrosis factor alpha protects against lethal West Nile virus infection by promoting trafficking of mononuclear leukocytes into the central nervous system. J. Virol. 2008, 82:8956-8964.
67. Sitati E., McCandless E.E., Klein R.S., Diamond M.S. CD40-CD40 ligand interactions promote trafficking of CD8+ T cells into the brain and protection against West Nile Virus Encephalitis. J. Virol. 2007, 81:9801-9811.
68. Su H.L., Liao C.L., Lin Y.L. Japanese encephalitis virus infection initiates endoplasmic reticulum stress and an unfolded protein response. J. Virol. 2002, 76:4162-4171.
69. Sui Y., Potula R., Dhillon N., Pinson D., Li S., Nath A., Anderson C., Turchan J., Kolson D., Narayan O., Buch S. Neuronal apoptosis is mediated by CXCL10 overexpression in simian human immunodeficiency virus encephalitis. Am. J. Pathol. 2004, 164:1557-1566.
70. Sui Y., Stehno-Bittel L., Li S., Loganathan R., Dhillon N.K., Pinson D., Nath A., Kolson D., Narayan O., Buch S. CXCL10-induced cell death in neurons: role of calcium dysregulation. Eur. J. Neurosci. 2006, 23:957-964.
71. Tamatani M., Che Y.H., Matsuzaki H., Ogawa S., Okado H., Miyake S., Mizuno T., Tohyama M. Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NFkappaB activation in primary hippocampal neurons. J. Biol. Chem. 1999, 274:8531-8538.
72. Taoufik E., Valable S., Muller G.J., Roberts M.L., Divoux D., Tinel A., Voulgari-Kokota A., Tseveleki V., Altruda F., Lassmann H., Petit E., Probert L. FLIP(L) protects neurons against in vivo ischemia and in vitro glucose deprivation-induced cell death. J. Neurosci. 2007, 27:6633-6646.
73. Taoufik E., Petit E., Divoux D., Tseveleki V., Mengozzi M., Roberts M.L., Valable S., Ghezzi P., Quackenbush J., Brines M., Cerami A., Probert L. TNF receptor I sensitizes neurons to erythropoietin- and VEGF-mediated neuroprotection after ischemic and excitotoxic injury. Proc. Natl. Acad. Sci. USA 2008, 105:6185-6190.
74. Tezel G., Yang X., Yang J., Wax M.B. Role of tumor necrosis factor receptor-1 in the death of retinal ganglion cells following optic nerve crush injury in mice. Brain Res. 2004, 996:202-212.
75. Tong N., Perry S.W., Zhang Q., James H.J., Guo H., Brooks A., Bal H., Kinnear S.A., Fine S., Epstein L.G., Dairaghi D., Schall T.J., Gendelman H.E., Dewhurst S., Sharer L.R., Gelbard H.A. Neuronal fractalkine expression in HIV-1 encephalitis: roles for macrophage recruitment and neuroprotection in the central nervous system. J. Immunol. 2000, 164:1333-1339.
76. Tran P.B., Banisadr G., Ren D., Chenn A., Miller R.J. Chemokine receptor expression by neural progenitor cells in neurogenic regions of mouse brain. J. Comp. Neurol. 2007, 500:1007-1033.
77. Walser T.C., Rifat S., Ma X., Kundu N., Ward C., Goloubeva O., Johnson M.G., Medina J.C., Collins T.L., Fulton A.M. Antagonism of CXCR3 inhibits lung metastasis in a murine model of metastatic breast cancer. Cancer Res. 2006, 66:7701-7707.
78. Weiss T.W., Samson A.L., Niego B., Daniel P.B., Medcalf R.L. Oncostatin M is a neuroprotective cytokine that inhibits excitotoxic injury in vitro and in vivo. FASEB J. 2006, 20:2369-2371.
79. Wijtmans M., Verzijl D., Leurs R., de Esch I.J., Smit M.J. Towards small-molecule CXCR3 ligands with clinical potential. ChemMedChem 2008, 3:861-872.
80. Xia M.Q., Bacskai B.J., Knowles R.B., Qin S.X., Hyman B.T. Expression of the chemokine receptor CXCR3 on neurons and the elevated expression of its ligand IP-10 in reactive astrocytes: in vitro ERK1/2 activation and role in Alzheimer's disease. J. Neuroimmunol. 2000, 108:227-235.
81. Yang J.S., Ramanathan M.P., Muthumani K., Choo A.Y., Jin S.H., Yu Q.C., Hwang D.S., Choo D.K., Lee M.D., Dang K., Tang W., Kim J.J., Weiner D.B. Induction of inflammation by West Nile virus capsid through the caspase-9 apoptotic pathway. Emerg. Infect. Dis. 2002, 8:1379-1384.
82. Zhang B., Yang L., Konishi Y., Maeda N., Sakanaka M., Tanaka J. Suppressive effects of phosphodiesterase type IV inhibitors on rat cultured microglial cells: comparison with other types of cAMP-elevating agents. Neuropharmacology 2002, 42:262-269.
83. Zhang B., Chan Y.K., Lu B., Diamond M.S., Klein R.S. CXCR3 mediates region-specific antiviral T cell trafficking within the central nervous system during West Nile Virus Encephalitis. J. Immunol. 2008, 180:2641-2649.
84. Zhu Y., Vergote D., Pardo C., Noorbakhsh F., McArthur J.C., Hollenberg M.D., Overall C.M., Power C. CXCR3 activation by lentivirus infection suppresses neuronal autophagy: neuroprotective effects of antiretroviral therapy. FASEB J. 2009.